The Czech government has decided not to ban HHC and kratom, two substances that have recently caused controversy. This decision is motivated by the conviction that a prohibitionist approach would not be realistic.
According to a proposed amendment currently being considered by the Czech Parliament, HHC and other synthetic psychoactive products will be restricted to persons over 18, may only be sold under the supervision of a salesperson and not in vending machines, and may not be advertised.
Experts hailed the move, saying these substances pose less risk than other drugs.
HHC is made by subjecting CBD to a synthetic process. The appearance of HHC raised the threat of a CBD ban in the Czech Republic, but this position was eventually abandoned by the government.
Earlier this year, the Czech Republic was identified as one of 20 or more EU countries where HHC products were widely available, prompting the European Monitoring Center for Drugs and Drug Addiction to issue health warnings. In March, the Czech government issued warnings about HHC, urging consumers to avoid these products due to potential health risks.
“Prohibition is not the solution”
“It became clear that outright prohibition was not the solution. Instead, the focus will be on greater protection for children and adult users,” according to the Czech Pirate Party, which supports the proposed amendment and, more broadly, the legalization of cannabis in the Czech Republic. “Instead of a ban, the focus will be on providing greater protection for users. »
Kratom, which had also been considered for banning, will also be regulated, but not banned, the health ministry said. Often used for its pain-relieving, uplifting, and mood-boosting effects, kratom is used to treat symptoms of opioid withdrawal, fatigue, and depression.